Conversely, ‘cold’ tumours scarcely expressing PD-L1, characterised by low mutational burden (low expression of neoantigens) and low expression of antigen presentation markers, such as major histocompatibility complex class I (MHC I) [4] are considered less responsive. Here, CD274 is linked to neoplasm.